Neuronetics Q4 EPS $(0.30) Beats $(0.38) Estimate, Sales $18.20M Beat $16.82M Estimate

Neuronetics (NASDAQ:STIM) reported quarterly losses of $(0.30) per share which beat the analyst consensus estimate of $(0.38) by 21.05 percent. This is a 3.45 percent decrease over losses of $(0.29) per share from the same period last year. The company reported quarterly sales of $18.20 million which beat the analyst consensus estimate of $16.82 million by 8.19 percent. This is a 21.14 percent increase over sales of $15.02 million the same period last year.